Leadership Overview
PiSA Pharmaceuticals has 10 executives leading key functions including strategy, human resources, finance, marketing, and operations.
Driven by a commitment to innovation, PiSA Pharmaceuticals advances pharmaceutical development and distribution, offering comprehensive laboratory hosting, production, and development services to enhance global health outcomes.
Driven by a commitment to innovation, PiSA Pharmaceuticals advances pharmaceutical development and distribution, offering comprehensive laboratory hosting, production, and development services to enhance global health outcomes.
Leadership Roles at PiSA Pharmaceuticals
Heriberto Castañeda - Chief Executive Officer, Pisa Pharma (Mexico)
Heriberto Castañeda, the Chief Executive Officer, Pisa Pharma (Mexico) at PiSA Pharmaceuticals, directs the overarching strategy and operational execution for the company's Mexican market. Castañeda leads all business functions, including pharmaceutical development, production, and distribution, ensuring alignment with global objectives. This executive role involves driving market expansion and fostering innovation within the pharmaceutical sector. By overseeing key strategic partnerships and resource allocation, Heriberto Castañeda strengthens PiSA Pharmaceuticals' position as a leader in Mexico. The Chief Executive Officer's responsibilities encompass financial performance, regulatory compliance, and cultivating a culture of excellence. Castañeda's leadership is fundamental to PiSA Pharmaceuticals' continued success and its commitment to providing essential healthcare solutions.
Fernando Garcia Mendez - Chief Financial Officer - Director Ejecutivo De Administración Y Soporte
Fernando Garcia Mendez, the Chief Financial Officer - Director Ejecutivo De Administración Y Soporte at PiSA Pharmaceuticals, oversees all financial operations and administrative support functions. Mendez directs financial planning, budgeting, and reporting, ensuring fiscal responsibility across the organization. This leadership role involves managing investments, optimizing resource allocation, and driving financial strategies to support PiSA Pharmaceuticals' development and distribution services. By ensuring robust administrative support, Fernando Garcia Mendez enhances operational efficiency and compliance. The Chief Financial Officer's responsibilities extend to risk management and providing strategic financial insights to the executive team. Mendez's financial acumen is crucial for PiSA Pharmaceuticals' sustained growth and market stability.
Alejandra Cardenas Castaños - Chief of Staff
Alejandra Cardenas Castaños, the Chief of Staff at PiSA Pharmaceuticals, directs strategic initiatives and operational alignment across key departments. Overseeing cross-functional project execution, Castaños ensures seamless integration of development and distribution services. This leadership role involves optimizing internal processes to support the company's mission of advancing pharmaceutical solutions. By fostering collaboration between research, production, and market outreach teams, Alejandra Cardenas Castaños drives efficiency and innovation. The Chief of Staff's responsibilities extend to managing critical stakeholder communications and supporting the executive leadership in achieving organizational objectives. This position is pivotal in translating high-level strategy into actionable operational plans, ensuring PiSA Pharmaceuticals maintains its competitive edge in the market.
Jesús Espinoza Díaz - Chief of Staff - Electrolit
Jesús Espinoza Díaz, the Chief of Staff - Electrolit at PiSA Pharmaceuticals, spearheads strategic operations specifically for the Electrolit division. Díaz manages the integration of production and distribution services, ensuring Electrolit's market presence is robust. This role involves close collaboration with marketing and development teams to launch new product initiatives. By focusing on operational excellence, Jesús Espinoza Díaz enhances the efficiency of Electrolit's supply chain and market penetration strategies. The Chief of Staff's purview includes driving key performance indicators and supporting the overall growth objectives of this vital business unit. Espinoza Díaz's leadership ensures that Electrolit consistently meets market demands and upholds PiSA Pharmaceuticals' commitment to quality.
Vanessa Barocio - Director Corporativa De Talento. Chief Human Resources Officer
Vanessa Barocio, the Director Corporativa De Talento. Chief Human Resources Officer at PiSA Pharmaceuticals, architects the company's talent acquisition, development, and retention strategies. Barocio oversees all human capital initiatives, ensuring alignment with PiSA Pharmaceuticals' growth objectives and its mission to advance pharmaceutical development. This leadership position involves cultivating a high-performance culture and fostering employee engagement across all operational facets. By implementing innovative HR programs, Vanessa Barocio strengthens the organizational capacity to deliver laboratory hosting, production, and development services. The Chief Human Resources Officer's responsibilities include managing compensation, benefits, and organizational design to support PiSA Pharmaceuticals' strategic direction and market impact.
Griselda Nájera Romero - Head Chief Marketing Officer, Technical NPI Projects
Griselda Nájera Romero, the Head Chief Marketing Officer, Technical NPI Projects at PiSA Pharmaceuticals, spearheads the go-to-market strategies for new pharmaceutical products. Romero directs all marketing initiatives, focusing on technical aspects of New Product Introduction (NPI) to ensure successful market launches. This role involves deep collaboration with research and development teams to translate scientific advancements into compelling market narratives. By analyzing market trends and consumer needs, Griselda Nájera Romero drives demand for PiSA Pharmaceuticals' innovative offerings. The Chief Marketing Officer's responsibilities include managing brand positioning, promotional campaigns, and market intelligence for technical projects. Romero's expertise is critical in positioning PiSA Pharmaceuticals at the forefront of pharmaceutical innovation.
Gilberto Guerrero Garcia - Jefe De Despacho
Gilberto Guerrero Garcia, the Jefe De Despacho at PiSA Pharmaceuticals, manages critical dispatch and logistics operations, ensuring the timely and efficient distribution of pharmaceutical products. Garcia oversees the coordination of transportation and inventory management, directly supporting the company's distribution services. This role involves optimizing delivery routes and ensuring compliance with all regulatory requirements for product handling. By maintaining high standards in dispatch operations, Gilberto Guerrero Garcia contributes to PiSA Pharmaceuticals' reputation for reliability. The Jefe De Despacho's responsibilities are integral to the supply chain, ensuring that laboratory hosting, production, and development services are effectively supported by seamless distribution.
Hiber Martinez Hernandez - Jefe De Despacho
Hiber Martinez Hernandez, the Jefe De Despacho at PiSA Pharmaceuticals, directs key aspects of the company's logistics and dispatch operations. Hernandez focuses on streamlining the movement of pharmaceutical goods, ensuring that production outputs reach their intended destinations efficiently. This position involves managing warehouse operations and coordinating with distribution partners to uphold service standards. By implementing effective dispatch protocols, Hiber Martinez Hernandez supports the broader operational goals of PiSA Pharmaceuticals. The Jefe De Despacho's contribution is vital for maintaining the integrity of the supply chain and ensuring customer satisfaction with the company's development and distribution services.
Carlos Ignacio - Jefe De Informacin Financiera
Carlos Ignacio, the Jefe De Informacin Financiera at PiSA Pharmaceuticals, leads the financial information department, providing critical data analysis and reporting. Ignacio oversees the generation of financial insights that support strategic decision-making across the organization. This role involves managing financial data integrity and ensuring accurate reporting for internal and external stakeholders. By delivering comprehensive financial intelligence, Carlos Ignacio aids in the effective management of PiSA Pharmaceuticals' resources. The Jefe De Informacin Financiera's responsibilities are essential for monitoring financial performance and supporting the company's objectives in pharmaceutical development and distribution.
Pedro Arrizon Delgadillo - Jefe De Despacho
Pedro Arrizon Delgadillo, the Jefe De Despacho at PiSA Pharmaceuticals, manages the operational flow of product dispatch, ensuring efficient delivery across all service areas. Delgadillo oversees the coordination of logistics and transportation, directly impacting the timely availability of pharmaceutical products. This role involves implementing best practices in dispatch management to enhance operational performance. By ensuring the smooth execution of dispatch protocols, Pedro Arrizon Delgadillo supports PiSA Pharmaceuticals' commitment to reliable distribution. The Jefe De Despacho's function is crucial for maintaining the company's supply chain efficiency and meeting market demands for its development and production services.
Explore Leadership Teams in Manufacturing
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.
Company Leadership
SE
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
TU
RL
CM
IFF Pharma Solutions develops high-quality pharmaceutical excipients and biopolymers that support advanced drug delivery and biomedical applications. The company focuses on providing reliable, performance-driven ingredients that help pharmaceutical manufacturers improve formulation efficiency, product stability, and patient outcomes. With strong expertise in quality, regulatory compliance, and innovation, IFF Pharma Solutions plays a key role in enabling safe and effective medicines worldwide.
Company Leadership
CP
ER
Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacturing of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval for Inflectra® and Remsima®, respectively, which is the world's first mAb biosimilar to receive approval from a regulatory agency in a developed country.
Company Leadership JS
LS
YK
YH
Frequently Asked Questions Regarding PiSA Pharmaceuticals Top Executives and Leadership Team
